EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers

Shichen Huang, Bowen Li, Huanyu Chen, Cheng Rong, Zheng Yang, Xianqin Zhang iD

Technology in Cancer Research & Treatment · 2025

DOI: 10.1177/15330338251315625 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Shichen Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Chengdu Medical College, 783 Xindu Avenue, Chengdu, 610500, Sichuan, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplasms, Gene Expression Regulation, Neoplastic, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Development and Regeneration Key Laboratory of Sichuan Province, Science & Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long non-coding RNAs (lncRNAs) are known to play vital roles in human cancers. LncRNA TRPM2-AS has been found to be upregulated in various types of cancers. The elevated levels of TRPM2-AS are associated with important clinicopathological parameters such as tumor size, tumor stage, and lymph node metastasis, revealing that TRPM2-AS could be a potential target for cancer diagnosis, prognosis and treatment. Moreover, TRPM2-AS is involved in regulating the cell proliferation, migration, invasion, apoptosis, drug or radio resistance by serving as a competing endogenous RNA, directly bounding to proteins and regulating multiple signaling pathways. In this review, we comprehensively summarize the latest knowledge on the aberrant expression of TRPM2-AS, the relationship between TRPM2-AS and clinical features, and the detailed mechanisms of potential functions of TRPM2-AS in various cancer types. The current study highlights the potential of TRPM2-AS as a prognostic and therapeutic target in cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingNeoplasmsGene Expression Regulation, NeoplasticBiomarkers, TumorTRPM Cation ChannelsHumansPrognosisCell ProliferationSignal TransductionApoptosisCell MovementClinical Relevance

Stichwörter der Autor:innen

TRPM2-ASceRNAclinical applicationlncRNAmolecular mechanism

Substanzen

RNA, Long NoncodingBiomarkers, TumorTRPM Cation ChannelsTRPM2 protein, human

Autor:innen und Institutionen

  • School of Clinical Medicine, Chengdu Medical College, 783 Xindu Avenue, Chengdu, 610500, Sichuan, China.
  • School of Basic Medical Sciences, Chengdu Medical College, 783 Xindu Avenue, Chengdu, 610500, Sichuan, China.

ORCID-Profile: Xianqin Zhang

Förderung

  • Development and Regeneration Key Laboratory of Sichuan Province
  • Science & Technology Department of Sichuan Province

Zitieren

APA

Huang, S., Li, B., Chen, H., Rong, C., Yang, Z., & Zhang, X. (2025). Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251315625

Vancouver

Huang S, Li B, Chen H, Rong C, Yang Z, Zhang X. Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251315625

BibTeX
@article{Huang2025,
  author = {Huang, Shichen and Li, Bowen and Chen, Huanyu and Rong, Cheng and Yang, Zheng and Zhang, Xianqin},
  title = {Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers},
  journal = {Technology in Cancer Research & Treatment},
  year = {2025},
  doi = {10.1177/15330338251315625}
}
Kostenlos starten →